| scholarly article | Q13442814 |
| P50 | author | Kerstin Brismar | Q37376842 |
| P2093 | author name string | Folke Lind | |
| Gun Jörneskog | |||
| Majid Kalani | |||
| Nazanin Naderi | |||
| P2860 | cites work | Microcirculation and diabetes | Q38694618 |
| Towards less amputations in diabetic patients. Incidence, causes, cost, treatment, and prevention--a review | Q40519462 | ||
| Health-related quality of life in patients with diabetes mellitus and foot ulcers. | Q51072191 | ||
| Continuous Transcutaneous Oxygen Tension Measured with a Heated Electrode | Q54649330 | ||
| Antibiotic prophylaxis in lower limb amputation | Q58248571 | ||
| Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers | Q58329838 | ||
| Dose-dependent hyperbaric oxygen stimulation of human fibroblast proliferation | Q58329851 | ||
| Transcutaneous oxygen tension measurements in the assessment of limb ischaemia | Q68005091 | ||
| Hyperbaric oxygen in diabetic gangrene treatment | Q68987735 | ||
| Superiority of transcutaneous oximetry in noninvasive vascular diagnosis in patients with diabetes | Q71383491 | ||
| Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting | Q71722724 | ||
| Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study | Q71829372 | ||
| The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks? | Q72188666 | ||
| Topical treatment of diabetic foot ulcers: an economic analysis of treatment alternatives and strategies | Q72220691 | ||
| Diabetic foot ulcers in a multidisciplinary setting. An economic analysis of primary healing and healing with amputation | Q72418131 | ||
| Change in major amputation rate in a center dedicated to diabetic foot care during the 1980s: prognostic determinants for major amputation | Q74480446 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 153-158 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | Journal of Diabetes and its Complications | Q15763696 |
| P1476 | title | Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers. Long-term follow-up | |
| P478 | volume | 16 |
| Q34704704 | A prospective, double-blind, randomized, controlled clinical trial comparing standard wound care with adjunctive hyperbaric oxygen therapy (HBOT) to standard wound care only for the treatment of chronic, non-healing ulcers of the lower limb in patie |
| Q37988910 | A retrospective study of diabetic foot ulcers treated with hyperbaric oxygen therapy |
| Q50479459 | A unique waterskiing injury leading to a necrotizing foot infection in an insulin-dependent diabetic. |
| Q38120754 | Adjunct methods of the standard diabetic foot ulceration therapy |
| Q35671644 | Advances in the treatment of the diabetic foot: Is there a role for adjunctive hyperbaric oxygen therapy? |
| Q40136343 | Amputation predictors in diabetic foot ulcers treated with hyperbaric oxygen |
| Q36837863 | Angiogenesis and vasculogenesis: inducing the growth of new blood vessels and wound healing by stimulation of bone marrow-derived progenitor cell mobilization and homing |
| Q33970150 | Can major amputation rates be decreased in diabetic foot ulcers with hyperbaric oxygen therapy? |
| Q35666348 | Clinical hyperbaric oxygen therapy, wound perfusion, and transcutaneous oximetry |
| Q37133401 | Cost-effectiveness and budget impact of adjunctive hyperbaric oxygen therapy for diabetic foot ulcers. |
| Q26781905 | Curbing Inflammation in Skin Wound Healing: A Review |
| Q78419821 | Current literature in diabetes |
| Q34930614 | Cutaneous wound healing: Current concepts and advances in wound care |
| Q35592344 | Diabetic foot ulcerations: management and adjunctive therapy |
| Q38022738 | Diabetic foot ulcers treated with hyperbaric oxygen therapy: a review of the literature |
| Q36938282 | Diabetic foot ulcers--a comprehensive review. |
| Q34357233 | Diagnosis and treatment of diabetic foot infections |
| Q37988404 | Diagnostics and treatment of the diabetic foot |
| Q88186401 | Effect of Hyperbaric Oxygen on Proliferation and Gene Expression of Human Chondrocytes: An In Vitro Study |
| Q38816987 | Effect of microtubule-associated protein-4 on epidermal cell migration under different oxygen concentrations |
| Q55651786 | Effects of repetitive hyperbaric oxygen treatment in patients with acute cerebral infarction: a pilot study. |
| Q40970065 | Evaluation of the efficacy of hyperbaric oxygen therapy in the management of chronic nonhealing ulcer and role of periwound transcutaneous oximetry as a predictor of wound healing response: A randomized prospective controlled trial |
| Q54652720 | Factors influencing the outcome of lower-extremity diabetic ulcers treated with hyperbaric oxygen therapy. |
| Q33739565 | Hyperbaric Oxygen Therapy for the Treatment of Diabetic Foot Ulcers: A Health Technology Assessment |
| Q33456149 | Hyperbaric medicine for the hospital-based physician |
| Q28569399 | Hyperbaric oxygen attenuates apoptosis and decreases inflammation in an ischemic wound model |
| Q88721778 | Hyperbaric oxygen can induce angiogenesis and recover erectile function |
| Q38213107 | Hyperbaric oxygen for the treatment of nonhealing arterial insufficiency ulcers |
| Q38259457 | Hyperbaric oxygen therapy and the possibility of ocular complications or contraindications |
| Q37608279 | Hyperbaric oxygen therapy as an anti-infective agent. |
| Q37978276 | Hyperbaric oxygen therapy as treatment of diabetic foot ulcers |
| Q33804804 | Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes |
| Q53388850 | Hyperbaric oxygen therapy for a neurologically devastated child: whose decision is it? |
| Q24187037 | Hyperbaric oxygen therapy for chronic wounds |
| Q24200177 | Hyperbaric oxygen therapy for chronic wounds |
| Q24247431 | Hyperbaric oxygen therapy for chronic wounds |
| Q34829597 | Hyperbaric oxygen therapy for diabetic ulcers: systematic review and meta-analysis |
| Q38027594 | Hyperbaric oxygen therapy for the management of chronic wounds |
| Q33699334 | Hyperbaric oxygen therapy for wound healing in diabetic rats: Varying efficacy after a clinically-based protocol |
| Q79293850 | Hyperbaric oxygen therapy of diabetic foot ulcers, transcutaneous oxymetry in clinical decision making |
| Q34243400 | Hyperbaric oxygen, vasculogenic stem cells, and wound healing |
| Q37825753 | Hyperbaric oxygen: its mechanisms and efficacy |
| Q33217001 | Hyperoxia improves microvascular perfusion in a murine wound model. |
| Q34094164 | In vivo assessment of peripheral vascular function by tcpO₂ and skin blood flow modelling. |
| Q53916731 | Intractable livedoid vasculopathy successfully treated with hyperbaric oxygen |
| Q43226423 | Livedoid Vasculopathy with Hyperhomocysteinemia Responding to Hyperbaric Oxygen Therapy |
| Q36729589 | Optimising antimicrobial therapy in diabetic foot infections |
| Q38636767 | Oxygen therapies and their effects on wound healing |
| Q58572713 | Oxygénothérapie hyperbare dans la prise en charge du pied diabétique: expérience d’un service de médecine interne à propos de 80 cas |
| Q50122860 | Perceptions of hyperbaric oxygen therapy among podiatrists practicing in high-risk foot clinics |
| Q44921005 | Point: hyperbaric oxygen is beneficial for diabetic foot wounds |
| Q46328207 | Reactive oxygen species, oxidative stress, glaucoma and hyperbaric oxygen therapy |
| Q51747711 | Relationship between ulcer healing after hyperbaric oxygen therapy and transcutaneous oximetry, toe blood pressure and ankle-brachial index in patients with diabetes and chronic foot ulcers. |
| Q31151097 | Rheopheresis in patients with ischemic diabetic foot syndrome: results of an open label prospective pilot trial |
| Q96136739 | Role of Hyperbaric Oxygen Therapy on Microvascular Diabetic Complications and Metabolic Profile among Patients with Type 2 Diabetes Mellitus |
| Q34726478 | Role of comorbidities as limiting factors to the effect of hyperbaric oxygen in diabetic foot patients: a retrospective analysis |
| Q80435171 | Role of hyperbaric oxygen therapy in the treatment of postoperative organ/space sternal surgical site infections |
| Q34420840 | Structural requirements for activation of latent platelet-derived growth factor CC by tissue plasminogen activator. |
| Q38889796 | The Difference Between the Healing and the Nonhealing Diabetic Foot Ulcer: A Review of the Role of the Microcirculation. |
| Q92713967 | The Role of VEGF and TNF-Alpha on Epithelialization of Diabetic Foot Ulcers after Hyperbaric Oxygen Therapy |
| Q55029105 | The analgesic effect of early hyperbaric oxygen treatment in chronic constriction injury rats and its influence on nNOS and iNOS expression and inflammatory factor production. |
| Q37923225 | The role of hyperbaric oxygen in the treatment of diabetic foot ulcers |
| Q33333612 | The use of hyperbaric oxygen therapy to treat chronic wounds: A review. |
| Q37870863 | What is the role of hyperbaric oxygen in the management of diabetic foot disease? |
Search more.